[1] Itoi T, Ohyashiki K, Yahata N, et al. Detection of telom-erase activity in exfloliated cancer cells obtained from bile[J]. Int J Oncol, 1999,15:1061-1067.
[2] Bryan TM, Cech TR. Telomerase maintenance of chromosome ends[J]. Curr Opin Biol, 1999,11:318-324.
[3] Hwang CF, Su CY, Kou SC, et al. Diagnostic usefulness of telomerase activity in nasopharyngeal carcinoma[J]. Jpn J Cancer Res, 2000, 91:706-766.
[4] Rha SY, Izbicka E, Lawrence R, et al. Effect of telomere and telomerase interactive agents on human tumor cell lines[J]. Clin Caner Res, 2000, 6:987-993.
[5] Feng J, Funk WD, Wang SS, et al. The RNA component human telomerase[J]. Science, 1995, 269:1236-1241.
[6] Karlseder J, Brocconi D, Dai Y, et al. P53- and ATM-dependent apoptosis induced by telomeres lacking TRF2[J]. Science, 1999,283:1321-1325.
[7] Kondo S, Tanaka Y, Kondo Y, et al. Antisense telomerase treatment, induction of two distinct pathway, apoptosis and differenciation[J]. FASEB J, 1998, 12:801-811.
[8] Finno P, Silver AR, Bouffler SD. Upregulation of telimerase activity by X-irradiation in mouse leukemia cells is independent of Tert,Terc,Tnks and Myc transcription[J]. Carcinogenesis, 2000, 21:573-578.
[9] Zhao P, Zhi JL, Yali L, et al. Expression telomerase reverse transcriptase in radiation-induced chronic human skin ulcer[J]. J Environ Pathol Toxicol Oncol, 2002, 21:67-70.
[10] Hande MP, Lansdorp MP and Natarajan AT. Induction of telomerase activity by in vivo X-irradiation of mouse splenocytes and its possible role in chromosome healing[J]. Mutat Res, 1998, 404:205-214.
[11] Lin Z, Lim S, Viani MA, et al. Down-regulation of telom-erase activity in malignant lymphomas by radiation and chemotherapeutic agents[J]. Am J Path, 2001, 159:711-719.